The market continues to test which projects can withstand intense pressure and which will fold. The Near Protocol (NEAR) price recovery has climbed past $2.60 before late selling trimmed gains, but its core support remains steady. The Ethereum (ETH) market outlook shows similar resilience, absorbing one of its largest selling days while holding the $3,640 base.
NEAR and ETH are showing strength in different ways. Separately, Cold Wallet (CWT) has published updates about its staged token sale. According to the project, Stage 17 pricing is set at $0.00998, with figures such as tokens sold and funds raised reported by the team. The project has also described a planned launch price of $0.3517, though any future market price is uncertain and not guaranteed.
NEAR Price Recovery Holds Structure Despite Volatility
The Near Protocol price recovery gained around 5% in 24 hours, moving from $2.47 to $2.60. Strong buying from larger players and daily trading volume of 3.36 million units drove the push higher. The move broke through a week-long consolidation between $2.47 and $2.52, establishing $2.51 as a firm support and testing $2.61 resistance.
However, as the day closed, profit-taking pulled the price back slightly, showing that short-term momentum may be cooling. Still, NEAR’s support structure remains intact, and a push past $2.65–$2.70 could set the stage for further upside, though outcomes remain uncertain. Macro trends will continue to influence its near-term direction.
Ethereum Market Outlook Balances Pressure and Growth
Ethereum faced one of its largest single-day sell-side events, with Net Taker Volume dropping by $418.8M. Despite that, ETH is still near $3,643, suggesting strong buy-side absorption. Network growth is also healthy, with nearly 30% more new addresses and higher active wallet counts this week.
The short-term focal point is $3,950 — breaking and holding above it could support a stronger uptrend, while falling short may extend consolidation or lead to a deeper pullback. For now, the balance between sell pressure and on-chain growth is keeping the outlook cautiously optimistic.
Cold Wallet: Stage 17 Token Sale Details (Project-Reported)
Cold Wallet has described Stage 17 of its token sale as part of a 150-stage pricing schedule. According to project materials, the Stage 17 price is $0.00998, and the team reports that more than 703 million CWT have been sold so far with over $5.9M raised. The project has also described a planned launch price of $0.3517 after the staged sale, though this is a project-stated target and not a guarantee of future market pricing.
Earlier stages were priced lower, and later stages are priced higher under the project’s stated schedule. As with any token sale, outcomes depend on execution, market conditions, and other factors, and published targets should not be treated as forecasts.
The project says it already serves more than 2 million active users through a “Plus Wallet” acquisition valued at $270M. It also states that its platform includes features such as gas fee rebates, tiered activity rewards, and crypto payment utilities. These claims have not been independently verified in this article.
Stage-based pricing structures can affect the effective entry price for different participants, but they do not determine how an asset will trade once it is publicly available.
Key Takeaway
NEAR’s latest climb shows it can break from consolidation, though late-day volatility remains a factor. Ethereum’s price action suggests it can endure elevated sell pressure alongside on-chain growth, with $3,950 acting as a key level for short-term sentiment.
Cold Wallet’s updates focus on its staged token sale and reported participation metrics, along with product and user claims described by the project. Readers should treat all sale-stage pricing and “launch price” statements as project-provided information rather than a prediction of returns.
This article contains information about a cryptocurrency token sale. This outlet is not affiliated with the project mentioned. This article is for informational purposes only and does not constitute financial or investment advice.
